Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Receivables (2016 - 2025)

InspireMD's Change in Receivables history spans 16 years, with the latest figure at $803000.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 347.08% year-over-year to $803000.0; the TTM value through Dec 2025 reached $596000.0, up 356.9%, while the annual FY2025 figure was $596000.0, 356.9% up from the prior year.
  • Change in Receivables reached $803000.0 in Q4 2025 per NSPR's latest filing, up from -$227000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $803000.0 in Q4 2025 to a low of -$332000.0 in Q2 2024.
  • Average Change in Receivables over 5 years is $79750.0, with a median of $10500.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: skyrocketed 2440.91% in 2021, then plummeted 16700.0% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $253000.0 in 2021, then plummeted by 58.1% to $106000.0 in 2022, then soared by 168.87% to $285000.0 in 2023, then tumbled by 214.04% to -$325000.0 in 2024, then soared by 347.08% to $803000.0 in 2025.
  • Per Business Quant, the three most recent readings for NSPR's Change in Receivables are $803000.0 (Q4 2025), -$227000.0 (Q3 2025), and $12000.0 (Q2 2025).